← Back to Search

Procedure

CTA/FFRct for Coronary Artery Disease (CRASCH-Liver Trial)

N/A
Waitlist Available
Led By Robert Safian, MD
Research Sponsored by William Beaumont Hospitals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

CRASCH-Liver Trial Summary

This trial is testing if CTA and CTA-derived Fractional Flow Reserve (FFRct) is better than the standard of care (consultation by cardiologist, echocardiogram, ECG, and stress tests) at diagnosing coronary artery disease (CAD) in patients with end-stage liver disease.

Eligible Conditions
  • Coronary Artery Disease
  • Acute Liver Failure
  • Liver Transplant

CRASCH-Liver Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in clinical recommendation
Secondary outcome measures
Cardiovascular morbidity
Frequency of Detecting Myocardial Ischemia and the frequency of detecting the correct territory of the Myocardial Ischemia.
Frequency of detecting Coronary Artery Disease (CAD) by CTA/FFRct
+1 more

CRASCH-Liver Trial Design

1Treatment groups
Experimental Treatment
Group I: Evaluation of Standard of care followed by CTA/FFRctExperimental Treatment2 Interventions
Patient received clinical recommendation based on the Standard of Care i.e 2 D echocardiogram, plus ECG, plus, pharmacological stress test followed by re-evaluation of clinical recommendation with addition of CTA/FFRct

Find a Location

Who is running the clinical trial?

William Beaumont HospitalsLead Sponsor
149 Previous Clinical Trials
112,858 Total Patients Enrolled
8 Trials studying Coronary Artery Disease
43,233 Patients Enrolled for Coronary Artery Disease
Robert Safian, MD3.52 ReviewsPrincipal Investigator - William Beaumont Hospitals
William Beaumont Hospitals
4 Previous Clinical Trials
2,159 Total Patients Enrolled
2 Trials studying Coronary Artery Disease
240 Patients Enrolled for Coronary Artery Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment still ongoing for this research project?

"As indicated on clinicaltrials.gov, this medical trial is no longer accepting patients as it was last updated on July 21st 2022 and first posted June 1st 2023. However, 659 other trials are actively searching for participants presently."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Cardiac Risk Assessment Using Standard of Care Versus CTA and Heart Flow FFRct
Robert Safian 2023. "Cardiac Risk Assessment Using Standard of Care Versus CTA and Heart Flow FFRct". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04089969.
~0 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top